SWP
SBIO icon

Stratos Wealth Partners’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Stratos Wealth Partners’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,444
Closed -$272K – 1340
2021
Q4 		$272K Buy
6,444
+309
+5% +$13.8K 0.01% 1032
2021
Q3 		$279K Hold
6,135
– – 0.01% 966
2021
Q2 		$300K Buy
6,135
+420
+7% +$20.1K 0.01% 969
2021
Q1 		$287K Sell
5,715
-370
-6% -$20.5K 0.01% 900
2020
Q4 		$312K Sell
6,085
-294
-5% -$14K 0.01% 840
2020
Q3 		$262K Buy
6,379
+700
+12% +$28.9K 0.01% 834
2020
Q2 		$238K Buy
+5,679
New +$224K 0.01% 842
2018
Q4 		– Sell
-355
Closed -$14K – 2185
2018
Q3 		$14K Buy
+355
New +$13.5K ﹤0.01% 2037
2018
Q2 		– Sell
-355
Closed -$12K – 2266
2018
Q1 		$12K Hold
355
– – ﹤0.01% 2241
2017
Q4 		$12K Buy
+355
New +$11.1K ﹤0.01% 2095
2016
Q1 		– Sell
-12,420
Closed -$394K – 633
2015
Q4 		$394K Buy
12,420
+4,927
+66% +$151K 0.03% 358
2015
Q3 		$209K Buy
+7,493
New +$262K 0.03% 474

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Stratos Wealth Partners's SBIO Position: Q1 2022 in Review

Stratos Wealth Partners sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2022, closing a stake of 6,444 shares — an estimated $272K sold.

Stratos Wealth Partners first reported a position in SBIO in Q3 2015 and held it in 12 quarters. The position peaked at $394K in Q4 2015. 56 funds tracked by Wall St. Rank hold SBIO as of Q1 2022.

  • Stratos Wealth Partners reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2022 after selling out during the quarter.
  • Stratos Wealth Partners sold 6,444 ALPS Medical Breakthroughs ETF shares in Q1 2022, an estimated $272K.
  • Stratos Wealth Partners first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and held it in 12 quarters.
  • Stratos Wealth Partners's ALPS Medical Breakthroughs ETF position peaked at $394K in Q4 2015.
  • 56 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2022.

Based on Stratos Wealth Partners's 13F filing for Q1 2022, filed 26 Apr 2022.